Real-world versus trial patients with transthyretin amyloid cardiomyopathy

Marco Canepa, Giacomo Tini, Beatrice Musumeci, Francesco Cappelli, Agnese Milandri, Roberta Mussinelli, Camillo Autore, Federico Perfetto, Claudio Rapezzi, Stefano Perlini

Research output: Contribution to journalLetter

Original languageEnglish
JournalEuropean Journal of Heart Failure
DOIs
Publication statusPublished - Jan 1 2019

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Canepa, M., Tini, G., Musumeci, B., Cappelli, F., Milandri, A., Mussinelli, R., Autore, C., Perfetto, F., Rapezzi, C., & Perlini, S. (2019). Real-world versus trial patients with transthyretin amyloid cardiomyopathy. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.1563